Earnings : What to expect NASDAQ:ACIU, NYSE:MEG, NASDAQ:ANNX, NASDAQ:MNPR

AC IMMUNE (NASDAQ:ACIU) EARNINGS INFORMATION (NASDAQ:ACIU)

AC Immune last issued its earnings data on March 22nd, 2021. The reported ($0.27) EPS for the quarter, missing the consensus estimate of ($0.25) by $0.02. AC Immune has generated $0.60 earnings per share over the last year. AC Immune has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Monday, May 3rd, 2021 based off prior year’s report dates.

IS AC IMMUNE A BUY RIGHT NOW? (NASDAQ:ACIU)

1 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for AC Immune in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” AC Immune stock.
AC Immune

MONTROSE ENVIRONMENTAL GROUP (NYSE:MEG) EARNINGS INFORMATION (NYSE:MEG)

Montrose Environmental Group last announced its earnings data on March 23rd, 2021. The reported ($0.22) earnings per share for the quarter, missing the consensus estimate of $0.14 by $0.36. Montrose Environmental Group has generated $0.00 earnings per share over the last year. Montrose Environmental Group has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Wednesday, June 23rd, 2021 based off prior year’s report dates.

IS MONTROSE ENVIRONMENTAL GROUP A BUY RIGHT NOW? (NYSE:MEG)

15 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Montrose Environmental Group in the last twelve months. There are currently 8 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “hold” Montrose Environmental Group stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MEG, but not buy additional shares or sell existing shares.
Montrose Environmental Group

ANNEXON (NASDAQ:ANNX) EARNINGS INFORMATION (NASDAQ:ANNX)

Annexon last posted its earnings data on March 24th, 2021. The reported ($0.61) EPS for the quarter, missing the consensus estimate of ($0.44) by $0.17. Annexon has generated $0.00 earnings per share over the last year. Annexon has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, June 24th, 2021 based off prior year’s report dates.

IS ANNEXON A BUY RIGHT NOW? (NASDAQ:ANNX)

5 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Annexon in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” Annexon stock.
Annexon

MONOPAR THERAPEUTICS (NASDAQ:MNPR) EARNINGS INFORMATION (NASDAQ:MNPR)

Monopar Therapeutics last posted its earnings results on March 24th, 2021. The reported ($0.18) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.02. Monopar Therapeutics has generated ($0.45) earnings per share over the last year. Monopar Therapeutics has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, May 6th, 2021 based off prior year’s report dates.

IS MONOPAR THERAPEUTICS A BUY RIGHT NOW? (NASDAQ:MNPR)

2 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Monopar Therapeutics in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should “buy” Monopar Therapeutics stock.
Monopar Therapeutics